LYPD9P

Across TCGA pan-cancer cohorts, LYPD9P RNA is linked to patient survival in 13 of 34 cancer types, making it the most broadly survival-associated LYPD9P data layer.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher LYPD9P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LYPD9P expression acts as an unfavorable survival marker, although some lineages such as ESCA and BRCA show a favorable association.

UCEC, KIRP, and UCS are the cancer types where LYPD9P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	OS	Tertile	III,IV	0.387	0.651	.021	60	view →
KIRP	DFS	Tertile	III,IV	0.092	0.540	<.001	49	view →
UCS	DFS	Tertile	IV	0.132	0.718	.002	36	view →
GBM	OS	Tertile	All	0.267	0.436	.005	18	view →
ESCA	OS	Tertile	III,IV	0.646	0.321	.008	16	view →
KIRC	DFS	Median	III,IV	0.576	0.682	.014	14	view →
COAD	OS	Tertile	All	0.653	0.879	.005	12	view →
LUSC	OS	Tertile	All	0.283	0.435	.018	12	view →
READ	DFS	Tertile	III,IV	0.224	0.613	.022	9	view →
ACC	OS	Tertile	All	0.202	0.628	.024	6	view →
SKCM	DFS	Quartile	III,IV	0.330	0.595	.024	4	view →
DLBC	DFS	Quartile	II,III,IV	0.386	0.856	.031	3	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 13 lineages.

LYPD9P–UCEC (OS)

Open the UCEC breakdown →